The present study shed light on the importance of TGM3 as a cancer prognostic biomarker and effective predictor of immunotherapy response as well as the relationship of TGM3 with immune modulators, prognosis, immune regulation and TME, aiding in the understanding of the potential mechanism between TGM3 and tumorigenesis and development. The gene discussed is TGM3; the disease is cancer.